These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17521798)

  • 1. Ajmaline challenge in Brugada syndrome.
    Mandelburger D; Teubl A; Röggla G
    Resuscitation; 2007 Aug; 74(2):393-4. PubMed ID: 17521798
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome.
    Govindan M; Batchvarov VN; Raju H; Shanmugam N; Bizrah M; Bastiaenen R; Kiotsekoglou A; Camm J; Behr ER
    Heart; 2010 Dec; 96(23):1904-8. PubMed ID: 20962343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ajmaline test].
    Said SM; Husser D; Bollmann A; Piorkowski C; Braun-Dullaeus RC
    Dtsch Med Wochenschr; 2010 Mar; 135(11):513-5. PubMed ID: 20221967
    [No Abstract]   [Full Text] [Related]  

  • 4. The ajmaline challenge and a strange ECG.
    Martini B
    Europace; 2009 Oct; 11(10):1406; author reply 1406-7. PubMed ID: 19797154
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients.
    Probst V; Sacher F; Derval N; Gourraud JB; Mabo P; Medkour F; Le Marec H; Gill J
    Europace; 2014 Jun; 16(6):908-13. PubMed ID: 24068444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ajmaline challenge in young individuals with suspected Brugada syndrome.
    Sorgente A; Sarkozy A; De Asmundis C; Chierchia GB; Capulzini L; Paparella G; Henkens S; Brugada P
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):736-41. PubMed ID: 21303388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ajmaline challenge for the diagnosis of Brugada syndrome: which protocol?
    Arnalsteen-Dassonvalle E; Hermida JS; Kubala M; Six I; Quenum S; Leborgne L; Jarry G
    Arch Cardiovasc Dis; 2010; 103(11-12):570-8. PubMed ID: 21147441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized and dynamic repolarization alternans in Ajmaline accentuated Brugada syndrome.
    Raviña T; Raviña M; Lapuerta JA
    Int J Cardiol; 2006 Jan; 106(1):119-22. PubMed ID: 16321676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative flecainide test in Brugada syndrome patients with previous positive response.
    Abello M; Merino JL; Peinado R; Gnoatto M
    Europace; 2006 Oct; 8(10):899-900. PubMed ID: 16887868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recording of high V1-V3 precordial leads may be essential to the diagnosis of Brugada syndrome during the ajmaline test.
    Teijeiro R; Garro HA; Acunzo RS; Albino E; Chiale PA
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):153-5. PubMed ID: 16891294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic predictors of Brugada type response during Na channel blockade challenge.
    Hermida JS; Denjoy I; Jarry G; Jandaud S; Bertrand C; Delonca J
    Europace; 2005 Sep; 7(5):447-53. PubMed ID: 16087108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

  • 15. Very prolonged episode of self-terminating ventricular fibrillation in a patient with Brugada syndrome.
    Boulé S; Kouakam C; Brigadeau F
    Can J Cardiol; 2013 Dec; 29(12):1742.e1-3. PubMed ID: 24267814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender difference and drug challenge in Brugada syndrome.
    Shimizu W
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):70-1. PubMed ID: 15028075
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity and specificity of sodium channel blocking test in the diagnosis of Brugada syndrome.
    Gavrielatos G; Letsas KP; Pappas LK; Efremidis M; Sideris A; Kardaras F
    Int J Cardiol; 2010 May; 141(2):e31-3. PubMed ID: 19141363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ajmaline challenge: to stop or not to stop..
    Probst V; Le Marec H
    Heart Rhythm; 2009 May; 6(5):632-3. PubMed ID: 19389650
    [No Abstract]   [Full Text] [Related]  

  • 19. Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy.
    Otten RF; Dusa AC; Das MK
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1039-42. PubMed ID: 17669093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of bipolar precordial leads in Brugada syndrome: more accurate, more simple, or more theoretical?
    Shimizu W
    Heart Rhythm; 2010; 7(2):216-7. PubMed ID: 20004624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.